Immunotherapy Effective in Rare Malignancies

]]>(MedPage Today) -- Anti-PD-1 immune checkpoint inhibition has once again proved its mettle in rare malignancies, yielding responses in patients with difficult-to-treat cutaneous T-cell lymphomas and advanced adrenocortical carcinoma, two small...